Between Two Ventricles™ HF Podcast
This cardiology podcast series focuses on all things related to heart failure. Leading specialists discuss the most up-to-date innovations, products and technologies affecting the heart failure patient population.
Listen to Our Most Recent Episode
GUIDE-HF: Triumphs and Controversies
Interview with JoAnn Lindenfeld, M.D., F.H.S.A. by Dr. Phil Adamson
November 9, 2023
Join JoAnn Lindenfeld, M.D., F.H.S.A, and Dr. Phil Adamson as they discuss triumphs and controversies of the GUIDE-HF trial. Dr. Lindenfeld addresses the amendment to the statistical analysis pre-pandemic, and the clinical application of GUIDE-HF data.
Hemodynamics and LVADs
Interview with Nir Uriel, MD, M.Sc., FACC by Dr. Phil Adamson
November 9, 2023
Symptoms are too late. In this episode, Nir Uriel, MD, M.Sc., FACC, joins Dr. Phil Adamson to discuss the impact of hemodynamic monitoring in slowing the progression of heart failure, and the negative impact of waiting for physical symptom manifestation in heart failure patients. Dr. Uriel shares how hemodynamic data serves as an objective tool to identify patients who may benefit from advanced heart failure therapies such as the HeartMate 3 LVAD.
History of Device Therapies in Heart Failure
Interview with Dr. William T. Abraham by Dr. Phil Adamson
November 9, 2023
Join Dr. William T. Abraham, M.D., FACP, FACC, FAHA, FESC, FRCPE, and Dr. Phil Adamson as they discuss the historical landscape of clinical trials and devices in the identification and management of heart failure.
From a Patient's Perspective: Alicia Nicoletti, CardioMEMS HF System Recipient
Interview with Alicia by Dr. Phil Adamson
November 9, 2023
When Alicia was 22 years-old, she was in a car accident that severed her coronary artery and caused severe injury to her heart. In 2015, she received her heart failure diagnosis. Alicia was implanted with the CardioMEMS™ HF System in 2021 at St. Francis Hospital. Listen in as Alicia shares her story with Dr. Phil Adamson.
Synergies of Hemodynamic Monitoring and Neurohormonal Intervention
Interview with Andrew Sauer, M.D. by Dr. Phil Adamson
November 9, 2023
In this episode, Andrew Sauer, M.D. joins Dr. Phil Adamson to discuss how volume management influences neurohormonal intervention, and the impact of guideline directed medical therapy on pulmonary vasoreactivity. Dr. Sauer reviews his approach to diuretic modifications post CardioMEMS HF System implant, and ability to make smarter treatment decisions by utilizing pulmonary artery pressures.
Nuts and Bolts of a Hemodynamic Program
Interview with Darshak Karia, M.D., FACC by Dr. Phil Adamson
November 9, 2023
Join Darshak Karia, M.D., FACC and Dr. Phil Adamson as they discuss the stark contrast in 5-year survival rates for patients with a breast cancer diagnosis and those with a heart failure diagnosis. Dr. Karia shares how the Piedmont Augusta HF program reached 73% reduction of HF hospitalizations by utilizing remote hemodynamic monitoring. Listen in as Dr. Karia and Dr. Adamson emphasize how heart failure affects us all.
From a Patient's Perpsective: Rob, HeartMate 3 LVAD Recipient
Interview with Rob by Dr. Phil Adamson
November 9, 2023
"My LVAD is giving me something that nothing else can: more time to spend with my family and friends." Join Rob and Dr. Adamson as they discuss Rob's heart failure diagnosis, HeartMate 3 LVAD implant, and Rob's active life post implant.
The Forgotten Ventricle
Interview with Ryan Tedford, MD, FACC, FAHA, FHFSA by Dr. Phil Adamson
November 9, 2023
In this episode, Ryan Tedford, MD, FACC, FAHA, FHFSA, joins Dr. Phil Adamson to discuss the mortality implications of right ventricular dysfunction in multiple disease states, and if there is an opportunity to take an oncologic approach to the treatment of heart failure. Listen in as Dr. Tedford discusses the treatment of secondary pulmonary hypertension and reducing stress on the right ventricle.
Underutilization of HeartMate 3 LVAD in Advanced Heart Failure
Interview with Michael Zhen-Yu Tong, M.D., MBA, FRCSC by Dr. Phil Adamson
November 9, 2023
In this episode, Michael Zhen-Yu Tong, M.D., MBA, FRCSC, joins Dr. Phil Adamson to discuss underutilization of left ventricular assist devices in advanced heart failure patients. Dr. Tong and Dr. Adamson emphasize how median survival with the HeartMate 3 LVAD reliably exceeds 5 years, even in those patients with refractory heart failure who are ineligible for transplantation.1 Listen in as Dr. Tong describes how he presents LVAD treatment options to heart failure patients who may not understand the seriousness or progression of their diagnosis.
From a Patient's Perpsective: Big John, CardioMEMS HF System, HeartMate 3 LVAD, and Heart Transplant Recipient
Interview with John by Dr. Phil Adamson
October 20, 2023
John, known in the rock and roll and wrestling worlds as Big John, had his first heart episode while snorkeling in Hawaii. Back on the mainland, he received a heart failure diagnosis. Tune in as Big John and Dr. Phil Adamson discuss his journey from CardioMEMS HF System, HeartMate 3 LVAD, and Heart Transplant.
From a Patient's Perpsective: Jermayne, HeartMate 3 LVAD Recipient
Interview with Jermayne by Dr. Phil Adamson
October 20, 2023
Jermayne was diagnosed with heart failure at just 23 years old. At 25, he was implanted with the HeartMate 3 LVAD at Cleveland Clinic. Jermayne is a newlywed, having married his wife and childhood friend, Keima in February of 2022. Join Jermayne as he shares his heart failure journey with Dr. Phil Adamson. Special delivery - Jermayne and Keima are expecting their first child.
Remote Hemodynamic Monitoring: The Totality of Evidence
Interview with Dr. Jennifer Cowger by Dr. Phil Adamson
June 5, 2023
Join Dr. Phil Adamson and Dr. Jennifer Cowger as they discuss how healthcare providers may redefine their response toward advanced heart failure patients who could be considered for durable MCS and the importance of a collaborative care model with advanced heart failure providers, local cardiologists, and primary care team.
Support provided by Abbott. The physician(s) worked on Abbott's behalf. The information is consistent with applicable FDA guidelines and is not intended for continuing education credits for healthcare professionals.
For more educational content on Abbott’s life-changing medical device technologies and resources, please visit cardiovascular.abbott.
References
- Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022;328(12):1233–1242. doi:10.1001/jama.2022.16197
- Scott, K. (2022). Simple changes lead to outsized improvements in healthcare. Clinical Laboratory News. July/August 2022 (Suppl.), 5-7. ADD-139842-GBL-EN.
MAT-2100531 v8.0